Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites von Neuschwander‐Tetri, Brent A.

Volltext

Non-alcoholic fatty liver disease von Neuschwander-Tetri, Brent A

Volltext

Therapeutic Landscape for NAFLD in 2020 von Neuschwander-Tetri, Brent A.

Volltext

Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit von Rotman, Yaron, Neuschwander‐Tetri, Brent A.

Volltext

Too Much Sugar—The Not‐So‐Sweet Reality of Its Impact on Our Health von Neuschwander‐Tetri, Brent A., Corey, Kathleen E., Malhi, Harmeet

Volltext

Mechanisms of NAFLD development and therapeutic strategies von Friedman, Scott L., Neuschwander-Tetri, Brent A., Rinella, Mary, Sanyal, Arun J.

Volltext

Carbohydrate intake and nonalcoholic fatty liver disease von Neuschwander-Tetri, Brent A

Volltext

Improvements in Histologic Features and Diagnosis Associated With Improvement in Fibrosis in Nonalcoholic Steatohepatitis: Results From the Nonalcoholic Steatohepatitis Clinical Re... von Brunt, Elizabeth M., Kleiner, David E., Wilson, Laura A., Sanyal, Arun J., Neuschwander‐Tetri, Brent A.

Volltext

Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis von Younossi, Zobair M., Loomba, Rohit, Anstee, Quentin M., Rinella, Mary E., Bugianesi, Elisabetta, Marchesini, Giulio, Neuschwander‐Tetri, Brent A., Serfaty, Lawrence, Negro, Francesco, Caldwell, Stephen H., Ratziu, Vlad, Corey, Kathleen E., Friedman, Scott L., Abdelmalek, Manal F., Harrison, Stephen A., Sanyal, Arun J., Lavine, Joel E., Mathurin, Philippe, Charlton, Michael R., Goodman, Zachary D., Chalasani, Naga P., Kowdley, Kris V., George, Jacob, Lindor, Keith

Volltext

Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis von Younossi, Zobair M., Loomba, Rohit, Rinella, Mary E., Bugianesi, Elisabetta, Marchesini, Giulio, Neuschwander‐Tetri, Brent A., Serfaty, Lawrence, Negro, Francesco, Caldwell, Stephen H., Ratziu, Vlad, Corey, Kathleen E., Friedman, Scott L., Abdelmalek, Manal F., Harrison, Stephen A., Sanyal, Arun J., Lavine, Joel E., Mathurin, Philippe, Charlton, Michael R., Chalasani, Naga P., Anstee, Quentin M., Kowdley, Kris V., George, Jacob, Goodman, Zachary D., Lindor, Keith

Volltext

Nonalcoholic Steatohepatitis and the Metabolic Syndrome von Neuschwander-Tetri, Brent A.

Volltext

Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease von Vuppalanchi, Raj, Siddiqui, Mohammad S., Van Natta, Mark L., Hallinan, Erin, Brandman, Danielle, Kowdley, Kris, Neuschwander‐Tetri, Brent A., Loomba, Rohit, Dasarathy, Srinivas, Abdelmalek, Manal, Doo, Edward, Tonascia, James A., Kleiner, David E., Sanyal, Arun J., Chalasani, Naga

Volltext

The Importance of Glycemic Equipoise in NASH von Allen, Alina M., Neuschwander‐Tetri, Brent A.

Volltext

NAFLD: Reporting Histologic Findings in Clinical Practice von Brunt, Elizabeth M., Kleiner, David E., Carpenter, Danielle H., Rinella, Mary, Harrison, Stephen A., Loomba, Rohit, Younossi, Zobair, Neuschwander‐Tetri, Brent A., Sanyal, Arun J.

Volltext

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease von Rinella, Mary E, Neuschwander-Tetri, Brent A, Siddiqui, Mohammad Shadab, Abdelmalek, Manal F, Caldwell, Stephen, Barb, Diana, Kleiner, David E, Loomba, Rohit

Volltext

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science von Siddiqui, Mohammad Shadab, Harrison, Stephen A., Abdelmalek, Manal F., Anstee, Quentin M., Bedossa, Pierre, Castera, Laurent, Dimick‐Santos, Lara, Friedman, Scott L., Greene, Katherine, Kleiner, David E., Megnien, Sophie, Neuschwander‐Tetri, Brent A., Ratziu, Vlad, Schabel, Elmer, Miller, Veronica, Sanyal, Arun J.

Volltext

Targeting the FXR Nuclear Receptor to Treat Liver Disease von Neuschwander-Tetri, Brent A

Volltext

Pegbelfermin (BMS‐986036), PEGylated FGF21, in Patients with Obesity and Type 2 Diabetes: Results from a Randomized Phase 2 Study von Charles, Edgar D., Neuschwander‐Tetri, Brent A., Pablo Frias, Juan, Kundu, Sudeep, Luo, Yi, Tirucherai, Giridhar S., Christian, Rose

Volltext

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings von Brunt, Elizabeth M., Kleiner, David E., Wilson, Laura A., Belt, Patricia, Neuschwander‐Tetri, Brent A.

Volltext

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease von Kowdley, Kris V., Belt, Patricia, Wilson, Laura A., Yeh, Matthew M., Neuschwander-Tetri, Brent A., Chalasani, Naga, Sanyal, Arun J., Nelson, James E.

Volltext